BioXClan is a venture capital firm established in 2018 and located in Seoul, South Korea. The firm focuses on investing in biotechnology and synthetic biology companies, targeting various stages of development from pre-seed to series A. BioXClan primarily concentrates its investments within South Korea, aiming to support innovative firms in these dynamic sectors.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.